Border

Inovio Receives FDA Approval for First DNA-Based Immunotherapy for Rare HPV-Related Disease

Border

Inovio Pharmaceuticals has received accelerated FDA approval for Voceryq, the first U.S.-approved plasmid DNA-based immunotherapy, offering a new treatment option for adults with recurrent respiratory papillomatosis (RRP). This rare, chronic disease is primarily caused by human papillomavirus (HPV) types 6 and 11 and leads to recurring, wart-like growths in the respiratory tract, including the vocal cords and airways.

Until now, treatment has primarily relied on repeated surgeries to remove these growths. Although surgery can relieve symptoms and improve breathing and speech, the growths often return, and repeated procedures carry risks, including potential permanent damage to the vocal cords and airways. Voceryq is designed to stimulate the body’s immune system to recognize and fight the HPV types responsible for the disease, potentially reducing the need for additional surgical interventions.

In a clinical trial involving 32 adults, seven of the 26 patients who had undergone at least three surgeries in the year before treatment required no additional surgery during the first year following treatment. Inovio estimates that at least 25,000 people in the United States are living with RRP, highlighting a significant unmet medical need.

The FDA granted Voceryq accelerated approval, meaning Inovio must conduct a confirmatory study to further verify its clinical benefit. The company plans to advance commercialization, with a full launch anticipated in the first quarter of 2027.

Why it matters: Voceryq’s approval represents a milestone for biotechnology and DNA-based medicine, demonstrating the potential of innovative immunotherapies to address rare diseases with limited treatment options. It also highlights the importance of continued clinical research, regulatory collaboration, and scientific innovation in bringing new therapies to patients.

Click here to read the entire article.

Did you find this helpful? Share with your network!

More Tips From The Bandish Group

Border Line

The Skills Employees Need to Succeed in the Age of AI

◆

Artificial intelligence is changing the workplace, but the skills employees need in the age of AI are not necessarily new.…

#455: Interview Questions for Hiring Managers: How to Identify the Right Candidate

◆

An effective interview is about more than confirming what’s already listed on a candidate’s resume. It’s an opportunity for hiring…

Scroll to Top